Anesthesia and postoperative cognitive dysfunction (POCD)

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 14, 2009, Pages 1568-1579

  Jungwirth, Bettina ^a   Zieglgänsberger, Walter ^b   Kochs, Eberhard ^a   Rammes, Gerhard ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; AMPA RECEPTOR; APOLIPOPROTEIN E4; ATROPINE; BENZODIAZEPINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; ETOMIDATE; GLUTAMATE RECEPTOR; GLYCINE RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; MAGNESIUM ION; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR; NITROUS OXIDE; OPIATE; PHOSPHOKINASE C; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOTRANSFERASE; PHYSOSTIGMINE; PROPOFOL; SCOPOLAMINE; SEROTONIN 3 RECEPTOR; UNCLASSIFIED DRUG; XENON;

ANTICHOLINERGIC SYNDROME; BRAIN PERFUSION; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; DELIRIUM; EXCITOTOXICITY; EXPLICIT MEMORY; GABAERGIC SYSTEM; GENERAL ANESTHESIA; HYPOTHERMIA; IMPLICIT MEMORY; LEARNING; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR;

EID: 77949902773     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709791012229     Document Type: Review

References (163)

1. Newman, M.F.; Grocott, H.P.; Mathew, J.P.; White, W.D.; Landolfo, K.; Reves, J.G.; Laskowitz, D.T.; Mark, D.B.; Blumenthal, J.A. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke, 2001, 32, 2874-2881.
2. Link, J.; Papadopoulos, G.; Dopjans, D.; Guggenmoos-Holzmann, I.; Eyrich, K. Distinct central anticholinergic syndrome following general anaesthesia. Eur. J. Anaesthesiol., 1997, 14, 15-23.
3. Schneck, H.J.; Rupreht, J. Central anticholinergic syndrome (CAS) in anesthesia and intensive care. Acta. Anaesthesiol. Belg., 1989, 40, 219-228.
4. Dyer, C.B.; Ashton, C.M.; Teasdale, T.A. Postoperative delirium. A review of 80 primary data-collection studies. Arch. Intern. Med., 1995, 155, 461-465.
5. Inouye, S.K. Delirium in older persons. N. Engl. J. Med., 2006, 354, 1157-1165.
6. Inouye, S.K.; van-Dyke, C.H.; Allessi, C.A. Clarifying confusion: The confusion assessment method. Ann. Intern. Med., 1990, 113, 941-948.
7. Folstein, M.F.; Folstein, S.E.; McHugh, P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res., 1975, 12, 189-198.
8. Jackson, J.C.; Gordon, S.M.; Hart, R.P.; Hopkins, R.O.; Ely, E.W. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol. Rev., 2004, 14, 87-98.
9. Newman, S.; Stygall, J.; Hirani, S.; Shaefi, S.; Maze, M. Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology, 2007, 106, 572-590.
10. Silverstein, J.H.; Steinmetz, J.; Reichenberg, A.; Harvey, P.D.; Rasmussen, L.S. Postoperative cognitive dysfunction in patients with preoperative cognitive impairment: which domains are most vulnerable? Anesthesiology, 2007, 106, 431-435.
11. Murkin, J.M.; Newman, S.P.; Stump, D.A.; Blumenthal, J.A. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann. Thorac. Surg., 1995, 59, 1289-1295.
12. Selnes, O.A.; McKhann, G.M. Coronary-artery bypass surgery and the brain. N. Engl. J. Med., 2001, 344, 451-452.
13. Rasmussen, L.S.; Larsen, K.; Houx, P.; Skovgaard, L.T.; Hanning, C.D.; Moller, J.T. The assessment of postoperative cognitive function. Acta. Anaesthesiol. Scand., 2001, 45, 275-289.
14. Moller, J.T.; Cluitmans, P.; Rasmussen, L.S.; Houx, P.; Rasmussen, H.; Canet, J.; Rabbitt, P.; Jolles, J.; Larsen, K.; Hanning, C.D.; Langeron, O.; Johnson, T.; Lauven, P.M.; Kristensen, P.A.; Biedler, A.; van Beem, H.; Fraidakis, O.; Silverstein, J.H.; Beneken, J.E.; Gravenstein, J.S. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet, 1998, 351, 857-861.
15. Newman, M.F.; Kirchner, J.L.; Phillips-Bute, B.; Gaver, V.; Grocott, H.; Jones, R.H.; Mark, D.B.; Reves, J.G.; Blumenthal, J.A. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N. Engl. J. Med., 2001, 344, 395-402.
16. Lee, T.A.; Wolozin, B.; Weiss, K.B.; Bednar, M.M. Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J. Alzheimers Dis., 2005, 7, 319-324.
17. Kat, M.G.; Vreeswijk, R.; de Jonghe, J.F.; van der Ploeg, T.; van Gool, W.A.; Eikelenboom, P.; Kalisvaart, K.J. Long-term cognitive outcome of delirium in elderly hip surgery patients. A prospective matched controlled study over two and a half years. Dement. Geriatr. Cogn. Disord., 2008, 26, 1-8.
18. Wacker, P.; Nunes, P.V.; Cabrita, H.; Forlenza, O.V. Postoperative delirium is associated with poor cognitive outcome and dementia. Dement. Geriatr. Cogn. Disord., 2006, 21, 221-227.
19. Monk, T.G.; Weldon, B.C.; Garvan, C.W.; Dede, D.E.; van der Aa, M.T.; Heilman, K.M.; Gravenstein, J.S. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology, 2008, 108, 18-30.
20. Maze, M.; Cibelli, M.; Grocott, H.P. Taking the lead in research into postoperative cognitive dysfunction. Anesthesiology, 2008, 108, 1-2.
21. Milner, B.; Squire, L.R.; Kandel, E.R. Cognitive neuroscience and the study of memory. Neuron, 1998, 20, 445-468.
22. Squire, L.R.; Zola-Morgan, S. The medial temporal lobe memory system. Science, 1991, 253, 1380-1386.
23. Malenka, R.C.; Bear, M.F. LTP and LTD: an embarrassment of riches. Neuron, 2004, 44, 5-21.
24. Cooke, S.F.; Bliss, T.V. Plasticity in the human central nervous system. Brain, 2006, 129, 1659-1673.
25. Parsons, C.G.; Danysz, W.; Quack, G. Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect., 1998, 11, 523-569.
26. Clements, J.D. Transmitter timecourse in the synaptic cleft: its role in central synaptic function. Trends Neurosci., 1996, 19, 163-171.
27. Nowak, L.; Bregestovski, P.; Ascher, P.; Herbert, A.; Prochiantz, A. Magnesium gates glutamate-activated channels in mouse central neurons. Nature, 1984, 307, 462-465.
28. Petrovic, M.; Horak, M.; Sedlacek, M.; Vyklicky, L., Jr. Physiology and pathology of NMDA receptors. Prague Med. Rep., 2005, 106, 113-136.
29. Arundine, M.; Tymianski, M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium, 2003, 34, 325-337.
30. Wenk, G.L. Neuropathologic changes in Alzheimer's disease: potential targets for treatment. J. Clin. Psychiatry, 2006, 67 Suppl 3, 3-7; quiz 23.
31. Byrnes, K.R.; Faden, A.I. Role of Cell Cycle Proteins in CNS Injury. Neurochem. Res., 2007, 32 (10), 1799-807.
32. Parsons, C.G.; Stoffler, A.; Danysz, W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse. Neuropharmacology, 2007, 53, 699-723.
33. Beracochea, D. Anterograde and retrograde effects of benzodiazepines on memory. Sci World J., 2006, 6, 1460-1465.
34. Danion, J.M.; Zimmermann, M.A.; Willard-Schroeder, D.; Grange, D.; Singer, L. Diazepam induces a dissociation between explicit and implicit memory. Psychopharmacology (Berl), 1989, 99, 238-243.
35. Lister, R.G. The amnesic action of benzodiazepines in man. Neurosci. Biobehav. Rev., 1985, 9, 87-94.
36. Savic, M.M.; Obradovic, D.I.; Ugresic, N.D.; Cook, J.M.; Sarma, P.V.; Bokonjic, D.R. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt. Psychopharmacology (Berl), 2005, 180, 455-465.
37. Curran, H.V.; Schifano, F.; Lader, M. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology (Berl), 1991, 103, 83-90.
38. Schwartz-Bloom, R.D.; Miller, K.A.; Evenson, D.A.; Crain, B.J.; Nadler, J.V. Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study. Neuroscience, 2000, 98, 471-484.
39. Kanter, E.D.; Kapur, A.; Haberly, L.B. A dendritic GABAA-mediated IPSP regulates facilitation of NMDA- mediated responses to burst stimulation of afferent fibers in piriform cortex. J. Neurosci., 1996, 16, 307-312.
40. Ohkuma, S.; Chen, S.H.; Katsura, M.; Chen, D.Z.; Kuriyama, K. Muscimol prevents neuronal injury induced by NMDA. Jpn. J. Pharmacol., 1994, 64, 125-128.
41. Weiser, T. AMPA receptor antagonists for the treatment of stroke. Curr Drug Targets CNS Neurol. Disord., 2005, 4, 153-159.
42. Johnson, T.; Monk, T.; Rasmussen, L.S.; Abildstrom, H.; Houx, P.; Korttila, K.; Kuipers, H.M.; Hanning, C.D.; Siersma, V.D.; Kristensen, D.; Canet, J.; Ibanaz, M.T.; Moller, J.T. Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology, 2002, 96, 1351-1357.
43. Hudetz, J.A.; Iqbal, Z.; Gandhi, S.D.; Patterson, K.M.; Hyde, T.F.; Reddy, D.M.; Hudetz, A.G.; Warltier, D.C. Postoperative cognitive dysfunction in older patients with a history of alcohol abuse. Anesthesiology, 2007, 106, 423-430.
44. Ancelin, M.L.; de Roquefeuil, G.; Ledesert, B.; Bonnel, F.; Cheminal, J.C.; Ritchie, K. Exposure to anaesthetic agents, cognitive functioning and depressive symptomatology in the elderly. Br. J. Psychiatry, 2001, 178, 360-366.
45. Kadoi, Y.; Saito, S.; Fujita, N.; Goto, F. Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes. J. Thorac. Cardiovasc. Surg., 2005, 129, 576-583.
46. Heyer, E.J.; Wilson, D.A.; Sahlein, D.H.; Mocco, J.; Williams, S.C.; Sciacca, R.; Rampersad, A.; Komotar, R.J.; Zurica, J.; Benvenisty, A.; Quest, D.O.; Todd, G.; Solomon, R.A.; Connolly, E.S., Jr. APOE-epsilon4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy. Neurology., 2005, 65, 1759-1763.
47. Leung, J.M.; Sands, L.P.; Wang, Y.; Poon, A.; Kwok, P.Y.; Kane, J.P.; Pullinger, C.R. Apolipoprotein E e4 allele increases the risk of early postoperative delirium in older patients undergoing noncardiac surgery. Anesthesiology, 2007, 107, 406-411.
48. Steed, L.; Kong, R.; Stygall, J.; Acharya, J.; Bolla, M.; Harrison, M.J.; Humphries, S.E.; Newman, S.P. The role of apolipoprotein E in cognitive decline after cardiac operation. Ann. Thorac. Surg., 2001, 71, 823-826.
49. Mathew, J.P.; Podgoreanu, M.V.; Grocott, H.P.; White, W.D.; Morris, R.W.; Stafford-Smith, M.; Mackensen, G.B.; Rinder, C.S.; Blumenthal, J.A.; Schwinn, D.A.; Newman, M.F. Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. J. Am. Coll. Cardiol., 2007, 49, 1934-1942.
50. Canet, J.; Raeder, J.; Rasmussen, L.S.; Enlund, M.; Kuipers, H.M.; Hanning, C.D.; Jolles, J.; Korttila, K.; Siersma, V.D.; Dodds, C.; Abildstrom, H.; Sneyd, J.R.; Vila, P.; Johnson, T.; Munoz Corsini, L.; Silverstein, J.H.; Nielsen, I.K.; Moller, J.T. Cognitive dysfunction after minor surgery in the elderly. Acta Anaesthesiol. Scand., 2003, 47, 1204-1210.
51. Heyer, E.J.; DeLaPaz, R.; Halazun, H.J.; Rampersad, A.; Sciacca, R.; Zurica, J.; Benvenisty, A.I.; Quest, D.O.; Todd, G.J.; Lavine, S.; Solomon, R.A.; Connolly, E.S., Jr. Neuropsychological dysfunction in the absence of structural evidence for cerebral ischemia after uncomplicated carotid endarterectomy. Neurosurgery, 2006, 58, 474-480; discussion 474-480.
52. Koch, S.; Forteza, A.; Lavernia, C.; Romano, J.G.; Campo-Bustillo, I.; Campo, N.; Gold, S. Cerebral fat microembolism and cognitive decline after hip and knee replacement. Stroke, 2007, 38, 1079-1081.
53. Hindman, B.J. Emboli, inflammation, and CNS impairment: an overview. Heart Surg. Forum, 2002, 5, 249-253.
54. Borger, M.A.; Feindel, C.M. Cerebral emboli during cardiopulmonary bypass: effect of perfusionist interventions and aortic cannulas. J. Extra Corpor. Technol., 2002, 34, 29-33.
55. Pugsley, W.; Klinger, L.; Paschalis, C.; Treasure, T.; Harrison, M.; Newman, S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke, 1994, 25, 1393-1399.
56. Mathew, J.P.; Grocott, H.P.; Phillips-Bute, B.; Stafford-Smith, M.; Laskowitz, D.T.; Rossignol, D.; Blumenthal, J.A.; Newman, M.F. Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. Stroke, 2003, 34, 508-513.
57. Paparella, D.; Yau, T.M.; Young, E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur. J. Cardiothorac. Surg., 2002, 21, 232-244.
58. Westaby, S.; Saatvedt, K.; White, S.; Katsumata, T.; van Oeveren, W.; Halligan, P.W. Is there a relationship between cognitive dysfunction and systemic inflammatory response after cardiopulmonary bypass? Ann. Thorac. Surg., 2001, 71, 667-672.
59. van Dijk, D.; Spoor, M.; Hijman, R.; Nathoe, H.M.; Borst, C.; Jansen, E.W.; Grobbee, D.E.; de Jaegere, P.P.; Kalkman, C.J. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA, 2007, 297, 701-708.
60. Selnes, O.A.; Grega, M.A.; Bailey, M.M.; Pham, L.D.; Zeger, S.L.; Baumgartner, W.A.; McKhann, G.M. Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann. Neurol., 2008, 63, 581-590.
61. Rodriguez, R.A.; Tellier, A.; Grabowski, J.; Fazekas, A.; Turek, M.; Miller, D.; Wherrett, C.; Villeneuve, P.J.; Giachino, A. Cognitive dysfunction after total knee arthroplasty: effects of intraoperative cerebral embolization and postoperative complications. J. Arthroplasty., 2005, 20, 763-771.
62. Wang, Y.; Sands, L.P.; Vaurio, L.; Mullen, E.A.; Leung, J.M. The effects of postoperative pain and its management on postoperative cognitive dysfunction. Am J Geriatr. Psychiatry, 2007, 15, 50-59.
63. Fong, H.K.; Sands, L.P.; Leung, J.M. The role of postoperative analgesia in delirium and cognitive decline in elderly patients: a systematic review. Anesth. Analg., 2006, 102, 1255-1266.
64. Grocott, H.P.; Mackensen, G.B.; Grigore, A.M.; Mathew, J.; Reves, J.G.; Phillips-Bute, B.; Smith, P.K.; Newman, M.F. Postoperative Hyperthermia Is Associated With Cognitive Dysfunction After Coronary Artery Bypass Graft Surgery. Stroke, 2002, 33, 537-541.
65. Urban, B.W.; Bleckwenn, M.; Barann, M. Interactions of anesthetics with their targets: non-specific, specific or both? Pharmacol. Ther., 2006, 111, 729-770.
66. Rudolph, U.; Antkowiak, B. Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci, 2004, 5, 709-720.
67. Yamakura, T.; Bertaccini, E.; Trudell, J.R.; Harris, R.A. Anesthetics and ion channels: molecular models and sites of action. Annu. Rev. Pharmacol. Toxicol., 2001, 41, 23-51.
68. Franks, N.P.; Lieb, W.R. Molecular and cellular mechanisms of general anaesthesia. Nature, 1994, 367, 607-614.
69. Pittson, S.; Himmel, A.M.; MacIver, M.B. Multiple synaptic and membrane sites of anesthetic action in the CA1 region of rat hippocampal slices. BMC. Neurosci., 2004, 5, 52.
70. Simon, W.; Hapfelmeier, G.; Kochs, E.; Zieglgansberger, W.; Rammes, G. Isoflurane blocks synaptic plasticity in the mouse hippocampus. Anesthesiology, 2001, 94, 1058-1065.
71. Haseneder, R.; Kurz, J.; Dodt, H.U.; Kochs, E.; Zieglgansberger, W.; Scheller, M.; Rammes, G.; Hapfelmeier, G. Isoflurane reduces glutamatergic transmission in neurons in the spinal cord superficial dorsal horn: evidence for a presynaptic site of an analgesic action. Anesthesiology, 2004, 98, 1718-1723.
72. Ranft, A.; Kurz, J.; Becker, K.; Dodt, H.U.; Zieglgansberger, W.; Rammes, G.; Kochs, E.; Eder, M. Nitrous oxide (N2O) pre- and postsynaptically attenuates NMDA receptor-mediated neurotransmission in the amygdala. Neuropharmacology, 2007, 52, 716-723.
73. Haseneder, R.; Kratzer, S.; Kochs, E.; Eckle, V.S.; Zieglgansberger, W.; Rammes, G. Xenon reduces N-methyl-D-aspartate and alpha-amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid receptor-mediated synaptic transmission in the amygdala. Anesthesiology, 2008, 109, 998-1006.
74. Jones, N.M.; Loiacono, R.E.; Beart, P.M. Roles for nitric oxide as an intra- and interneuronal messenger at NMDA release-regulating receptors: evidence from studies of the NMDA-evoked release of [3H]noradrenaline and D-[3H]aspartate from rat hippocampal slices. J. Neurochem., 1995, 64, 2057-2063.
75. Nishikawa, K.; Jenkins, A.; Paraskevakis, I.; Harrison, N.L. Volatile anesthetic actions on the GABAA receptors: contrasting effects of alpha 1(S270) and beta 2(N265) point mutations. Neuropharmacology, 2002, 42, 337-345.
76. Caraiscos, V.B.; Newell, J.G.; You-Ten, K.E.; Elliott, E.M.; Rosahl, T.W.; Wafford, K.A.; MacDonald, J.F.; Orser, B.A. Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane. J. Neurosci., 2004, 24, 8454-8458.
77. Marota, J.J.; Crosby, G.; Uhl, G.R. Selective effects of pentobarbital and halothane on c-fos and jun-B gene expression in rat brain. Anesthesiology, 1992, 77, 365-371.
78. Culley, D.J.; Yukhananov, R.Y.; Xie, Z.; Gali, R.R.; Tanzi, R.E.; Crosby, G. Altered hippocampal gene expression 2 days after general anesthesia in rats. Eur. J. Pharmacol., 2006, 549, 71-78.
79. Futterer, C.D.; Maurer, M.H.; Schmitt, A.; Feldmann, R.E., Jr.; Kuschinsky, W.; Waschke, K.F. Alterations in rat brain proteins after desflurane anesthesia. Anesthesiology, 2004, 100, 302-308.
80. Rammes, G.; Starker, L.K.; Haseneder, R.; Berkmann, J.; Plack, A.; Zieglgansberger, W.; Ohl, F.; Kochs, E.F.; Blobner, M. Isoflurane anaesthesia reversibly improves cognitive function and longterm potentiation (LTP) via an up-regulation in NMDA receptor 2B subunit expression. Neuropharmacology, 2009, 56, 626-636.
81. Pocock, G.; Richards, C.D. Excitatory and inhibitory synaptic mechanisms in anaesthesia. Br. J. Anaesthesia, 1993, 71, 134-147.
82. Franks, N.P.; Honore, E. The TREK K2P channels and their role in general anaesthesia and neuroprotection. [Review] [65 refs]. Trends Pharmacol. Sci., 2004, 25, 601-608.
83. Haseneder, R.; Kratzer, S.; Kochs, E.; Eckle, V.-S.; Zieglgansberger, W.; Rammes, G. Xenon reduces N-methyl-D-aspartate and alpha-amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid receptor-mediated synaptic transmission in the amygdala. Anesthesiology, 2008, 109, 998-1006.
84. Cheng, V.Y.; Martin, L.J.; Elliott, E.M.; Kim, J.H.; Mount, H.T.J.; Taverna, F.A.; Roder, J.C.; Macdonald, J.F.; Bhambri, A.; Collinson, N.; Wafford, K.A.; Orser, B.A. Alpha5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate. J. Neurosci., 2006, 26, 3713-3720.
85. Wainwright, A.; Sirinathsinghji, D.J.; Oliver, K.R. Expression of GABA(A) receptor alpha5 subunit-like immunoreactivity in human hippocampus. Brain Res. Mol. Brain. Res., 2000, 80, 228-232.
86. Collinson, N.; Kuenzi, F.M.; Jarolimek, W.; Maubach, K.A.; Cothliff, R.; Sur, C.; Smith, A.; Otu, F.M.; Howell, O.; Atack, J.R.; McKernan, R.M.; Seabrook, G.R.; Dawson, G.R.; Whiting, P.J.; Rosahl, T.W. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J. Neurosci., 2002, 22, 5572-5580.
87. Wei, H.; Xiong, W.; Yang, S.; Zhou, Q.; Liang, C.; Zeng, B.X.; Xu, L. Propofol facilitates the development of long-term depression (LTD) and impairs the maintenance of long-term potentiation (LTP) in the CA1 region of the hippocampus of anesthetized rats. Neurosci. Lett., 2002, 324, 181-184.
88. Takamatsu, I.; Sekiguchi, M.; Wada, K.; Sato, T.; Ozaki, M. Propofol-mediated impairment of CA1 long-term potentiation in mouse hippocampal slices. Neurosci. Lett., 2005, 389, 129-132.
89. Veselis, R.A.; Reinsel, R.A.; Feshchenko, V.A.; Wronski, M. The comparative amnestic effects of midazolam, propofol, thiopental, and fentanyl at equisedative concentrations. Anesthesiology, 1997, 87, 749-764.
90. MacIver, M.B.; Tauck, D.L.; Kendig, J.J. General anaesthetic modification of synaptic facilitation and long-term potentiation in hippocampus. Br. J. Anaesthesia., 1989, 62, 301-310.
91. Hecker, K.; Baumert, J.H.; Horn, N.; Rossaint, R. Xenon, a modern anaesthesia gas. Minerva Anestesiol., 2004, 70, 255-260.
92. El-Zahaby, H.M.; Ghoneim, M.M.; Block, R.I. The interaction between nitrous oxide and isoflurane on suppression of learning: a study using classical conditioning in rabbits. Acta. Anaesthesiol Scand., 1996, 40, 798-803.
93. Rabat, A.; Hardouin, J.; Courtiere, A. Nitrous oxide impairs selective stages of working memory in rats. Neurosci. Lett., 2004, 364, 22-26.
94. Dutton, R.C.; Maurer, A.J.; Sonner, J.M.; Fanselow, M.S.; Laster, M.J.; Eger, E.I. The concentration of isoflurane required to suppress learning depends on the type of learning. Anesthesiology, 94(3):514-519,, 2001.
95. Alkire, M.T.; Nathan, S.V.; McReynolds, J.R. Memory enhancing effect of low-dose sevoflurane does not occur in basolateral amygdala-lesioned rats. Anesthesiology, 2005, 103, 1167-1173.
96. Komatsu, H.; Nogaya, J.; Anabuki, D.; Yokono, S.; Kinoshita, H.; Shirakawa, Y.; Ogli, K. Memory facilitation by posttraining exposure to halothane, enflurane, and isoflurane in ddN mice. Anesth. Analg., 1993, 76, 609-612.
97. Engeland, C.G.; Vanderwolf, C.H.; Gelb, A.W. Rats show unimpaired learning within minutes after recovery from single bolus propofol anesthesia. Can. J. Anaesth., 1999, 46, 586-592.
98. Lee, I.H.; Culley, D.J.; Baxter, M.G.; Xie, Z.; Tanzi, R.E.; Crosby, G. Spatial memory is intact in aged rats after propofol anesthesia. Anesth. Analg., 2008, 107, 1211-1215.
99. Culley, D.J.; Baxter, M.G.; Crosby, C.A.; Yukhananov, R.; Crosby, G. Impaired acquisition of spatial memory 2 weeks after isoflurane and isoflurane-nitrous oxide anesthesia in aged rats. Anesth. Analg., 2004, 99, 1393-1397.
100. Culley, D.J.; Baxter, M.; Yukhananov, R.; Crosby, G. The memory effects of general anesthesia persist for weeks in young and aged rats. Anesth. Analg., 2003, 96, 1004-1009.
101. Crosby, C.; Culley, D.J.; Baxter, M.G.; Yukhananov, R.; Crosby, G. Spatial memory performance 2 weeks after general anesthesia in adult rats. Anesthesiology, 2005, 101, 1389-1392.
102. Bekker, A.; Shah, R.; Quartermain, D.; Li, Y.-S.; Blanck, T. Isoflurane preserves spatial working memory in adult mice after moderate hypoxia. Anesthesiology, 2006, 102, 1134-1138.
103. Valentim, A.M.; Alves, H.C.; Olsson, I.A.; Antunes, L.M. The effects of depth of isoflurane anesthesia on the performance of mice in a simple spatial learning task. J Am. Assoc. Lab. Anim. Sci., 2008, 47, 16-19.
104. Rasmussen, L.S.; Johnson, T.; Kuipers, H.M.; Kristensen, D.; Siersma, V.D.; Vila, P.; Jolles, J.; Papaioannou, A.; Abildstrom, H.; Silverstein, J.H.; Bonal, J.A.; Raeder, J.; Nielsen, I.K.; Korttila, K.; Munoz, L.; Dodds, C.; Hanning, C.D.; Moller, J.T. Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol. Scand., 2003, 47, 260-266.
105. Williams-Russo, P.; Sharrock, N.E.; Mattis, S.; Szatrowski, T.P.; Charlson, M.E. Cognitive effects after epidural vs general anesthesia in older adults. A randomized trial. JAMA, 1995, 274, 44-50.
106. Kawaguchi, M.; Furuya, H.; Patel, P. Neuroprotective effects of anesthetic agents. J. Anesth., 2005, 19, 150-156.
107. Fukuda, S.; Warner, D.S. Cerebral protection. Br. J. Anaesth., 2007, 99, 10-17.
108. Beirne, J.P.; Pearlstein, R.D.; Massey, G.W.; Warner, D.S. Effect of halothane in cortical cell cultures exposed to N-methyl-D-aspartate. Neurochem. Res., 1998, 23, 17-23.
109. Harada, H.; Kelly, P.J.; Cole, D.J.; Drummond, J.C.; Patel, P.M. Isoflurane reduces N-methyl-D-aspartate toxicity in vivo in the rat cerebral cortex. Anesth. Analg., 1999, 89, 1442-1447.
110. Kimbro, J.R.; Kelly, P.J.; Drummond, J.C.; Cole, D.J.; Patel, P.M. Isoflurane and pentobarbital reduce AMPA toxicity in vivo in the rat cerebral cortex. Anesthesiology, 2000, 92, 806-812.
111. Bickler, P.E.; Warner, D.S.; Stratmann, G.; Schuyler, J.A. gamma-Aminobutyric acid-A receptors contribute to isoflurane neuroprotection in organotypic hippocampal cultures. Anesthesiology, 2003, 97, 564-571.
112. Mackensen, G.B.; Nellgard, B.; Miura, Y.; Chu, C.T.; Dexter, F.; Pearlstein, R.D.; Warner, D.S. Sympathetic ganglionic blockade masks beneficial effect of isoflurane on histologic outcome from near-complete forebrain ischemia in the rat. Anesthesiology, 1999, 90, 873-881.
113. Patel, A.J.; Honore, E.; Lesage, F.; Fink, M.; Romey, G.; Lazdunski, M. Inhalational anesthetics activate two-pore-domain background K+ channels. Nat. Neurosci., 1999, 2, 422-426.
114. Heurteaux, C.; Guy, N.; Laigle, C.; Blondeau, N.; Duprat, F.; Mazzuca, M.; Lang-Lazdunski, L.; Widmann, C.; Zanzouri, M.; Romey, G.; Lazdunski, M. TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J., 2004, 23, 2684-2695.
115. Gelb, A.W.; Bayona, N.A.; Wilson, J.X.; Cechetto, D.F. Propofol anesthesia compared to awake reduces infarct size in rats. Anesthesiology, 2002, 96, 1183-1190.
116. Pittman, J.E.; Sheng, H.; Pearlstein, R.; Brinkhous, A.; Dexter, F.; Warner, D.S. Comparison of the effects of propofol and pentobarbital on neurologic outcome and cerebral infarct size after temporary focal ischemia in the rat. Anesthesiology, 1997, 87, 1139-1144.
117. Natale, G.; Cattano, D.; Abramo, A.; Forfori, F.; Fulceri, F.; Fornai, F.; Paparelli, A.; Giunta, F. Morphological evidence that xenon neuroprotects against N-methyl-DL-aspartic acid-induced damage in the rat arcuate nucleus: a time-dependent study. Ann. N. Y. Acad. Sci., 2006, 1074, 650-658.
118. Turner, B.K.; Wakim, J.H.; Secrest, J.; Zachary, R. Neuroprotective effects of thiopental, propofol, and etomidate. AANA J., 2005, 73, 297-302.
119. Wei, H.; Kang, B.; Wei, W.; Liang, G.; Meng, Q.C.; Li, Y.; Eckenhoff, R.G. Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res., 2005, 1037, 139-147.
120. Kullmann, D.M.; Asztely, F. Extrasynaptic glutamate spillover in the hippocampus: evidence and implications. Trends Neurosci., 1998, 21, 8-14.
121. Rusakov, D.A.; Kullmann, D.M. Extrasynaptic glutamate diffusion in the hippocampus: ultrastructural constraints, uptake, and receptor activation. J. Neurosci., 1998, 18, 3158-3170.
122. Murry, C.E.; Jennings, R.B.; Reimer, K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986, 74, 1124-1136.
123. Reimer, K.A.; Jennings, R.B. Ischemic preconditioning: a brief review. Basic Res Cardiol., 1996, 91, 1-4.
124. Ferrari, R.; Ceconi, C.; Curello, S.; Percoco, G.; Toselli, T.; Antonioli, G. Ischemic preconditioning, myocardial stunning, and hibernation: basic aspects. Am. Heart J., 1999, 138, S61-68.
125. Payne, R.S.; Akca, O.; Roewer, N.; Schurr, A.; Kehl, F. Sevoflurane-induced preconditioning protects against cerebral ischemic neuronal damage in rats. Brain Res., 2005, 1034, 147-152.
126. Zheng, S.; Zuo, Z. Isoflurane preconditioning reduces purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience, 2003, 118, 99-106.
127. Wang, C.; Jin Lee, J.; Jung, H.H.; Zuo, Z. Pretreatment with volatile anesthetics, but not with the nonimmobilizer 1,2-dichlorohexafluorocyclobutane, reduced cell injury in rat cerebellar slices after an in vitro simulated ischemia. Brain Res., 2007, 1152, 201-208.
128. Clarkson, A.N. Anesthetic-mediated protection/preconditioning during cerebral ischemia. Life Sci., 2007, 80, 1157-1175.
129. Farag, E.; Chelune, G.J.; Schubert, A.; Mascha, E.J. Is depth of anesthesia, as assessed by the Bispectral Index, related to postoperative cognitive dysfunction and recovery? Anesth. Analg., 2006, 103, 633-640.
130. Monk, T.G.; Saini, V.; Weldon, B.C.; Sigl, J.C. Anesthetic management and one-year mortality after noncardiac surgery. Anesth. Analg., 2005, 100, 4-10.
131. Nussmeier, N.A.; Arlund, C.; Slogoff, S. Neuropsychiatric complications after cardiopulmonary bypass: Cerebral protection by a barbiturate. Anesthesiology, 1986, 64, 165-170.
132. Zaidan, J.; Klochany, A.; Martin, W.; Ziegler, J.; Harless, D.; Andrews, R. Effect of thiopental on neurologic outcome following coronary artery bypass grafting. Anesthesiology, 1991, 74, 406-411.
133. Roach, G.; Newman, M.; Murkin, J.; Marztke, J.; Ruskin, A.; Li, J.; Guo, A.; Wisniewski, A.; Mangano, D.; Group, f.T.M.S.o.P.I.M.R. Ineffectivness of burst suppression therapy in mitigating perioperative cerebrovascular dysfunction. Anesthesiology, 1999, 90, 1255-1264.
134. Arrowsmith, J.E.; Harrison, M.J.; Newman, S.P.; Stygall, J.; Timberlake, N.; Pugsley, W.B. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke, 1998, 29, 2357-2362.
135. Nagels, W.; Demeyere, R.; Van Hemelrijck, J.; Vandenbussche, E.; Gijbels, K.; Vandermeersch, E. Evaluation of the neuroprotective effects of S(+)-ketamine during open-heart surgery. Anesth. Analg., 2004, 98, 1595-1603.
136. Nasu, I.; Yokoo, N.; Takaoka, S.; Takata, K.; Hoshikawa, T.; Okada, M.; Miura, Y. The dose-dependent effects of isoflurane on outcome from severe forebrain ischemia in the rat. Anesth. Analg., 2006, 103, 413-418.
137. Kadoi, Y.; Goto, F. Sevoflurane anesthesia did not affect postoperative cognitive dysfunction in patients undergoing coronary artery bypass graft surgery. J. Anesth., 2007, 21, 330-335.
138. Kanbak, M.; Saricaoglu, F.; Akinci, S.B.; Oc, B.; Balci, H.; Celebioglu, B.; Aypar, U. The effects of isoflurane, sevoflurane, and desflurane anesthesia on neurocognitive outcome after cardiac surgery: a pilot study. Heart Surg. Forum, 2007, 10, E36-41.
139. Elsersy, H.; Sheng, H.; Lynch, J.R.; Moldovan, M.; Pearlstein, R.D.; Warner, D.S. Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term outcome from severe forebrain ischemia in the rat. Anesthesiology, 2004, 100, 1160-1166.
140. Sakai, H.; Sheng, H.; Yates, R.B.; Ishida, K.; Pearlstein, R.D.; Warner, D.S. Isoflurane provides long-term protection against focal cerebral ischemia in the rat. Anesthesiology, 2007, 106, 92-99.
141. Sanders, R.D.; Xu, J.; Shu, Y.; Fidalgo, A.; Ma, D.; Maze, M. General anesthetics induce apoptotic neurodegeneration in the neonatal rat spinal cord. Anesth. Analg., 2008, 106, 1708-1711.
142. Head, B.P.; Patel, H.H.; Niesman, I.R.; Drummond, J.C.; Roth, D.M.; Patel, P.M. Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system. Anesthesiology, 2009, 110, 813-825.
143. Loepke, A.W.; Istaphanous, G.K.; McAuliffe, J.J., 3rd; Miles, L.; Hughes, E.A.; McCann, J.C.; Harlow, K.E.; Kurth, C.D.; Williams, M.T.; Vorhees, C.V.; Danzer, S.C. The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory. Anesth. Analg., 2009, 108, 90-104.
144. Satomoto, M.; Satoh, Y.; Terui, K.; Miyao, H.; Takishima, K.; Ito, M.; Imaki, J. Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology, 2009, 110, 628-637.
145. Patel, P.; Sun, L. Update on neonatal anesthetic neurotoxicity: insight into molecular mechanisms and relevance to humans. Anesthesiology, 2009, 110, 703-708.
146. Mellon, R.D.; Simone, A.F.; Rappaport, B.A. Use of anesthetic agents in neonates and young children. Anesth. Analg., 2007, 104, 509-520.
147. Ben-Ari, Y.; Khazipov, R.; Leinekugel, X.; Caillard, O.; GaiarsaJL. GABAA, NMDA and AMPA receptors: a developmentally regulated 'menage a trois'. Trends Neurosci., 1997, 20, 523-529.
148. Michenfelder, J.; Milde, J. The relationship among canine brain temperature, metabolism, and function during hypothermia. Anesthesiology, 1991, 75, 130-136.
149. Busto, R.; Globus, M.; Dietrich, W.; Martinez, E.; Valdes, I.; Ginsberg, M. Effect of Mild Hypothermia no Ischemia-Induced Release of Neurotransmitters and Free Fatty Acids in Rat Brain. Stroke, 1989, 20, 904-910.
150. Bickler, P.E.; Buck, L.T.; Hansen, B.M. Effects of isoflurane and hypothermia on glutamate receptor-mediated calcium influx in brain slices. Anesthesiology, 1994, 81, 1461-1469.
151. Globus, M.Y.T.; Busto, R.; Lin, B.; Schnippering, H.; Ginsberg, M.D. Detection of free radical activity during transient global ischemia and recirculation: Effects of intraischemic brain temperature modulation. J. Neurochem., 1995, 65, 1250-1256.
152. Kader, A.; Frazzini, V.; Baker, C.; Solomon, R.; Trifiletti, R. Effect of mild hypothermia on nitric oxide synthesis during focal cerebral ischemia. Neurosurgery, 1994, 35, 272-277.
153. Mora, C.T.; Henson, M.B.; Weintraub, W.S.; Murjin, J.M.; Martin, T.D. The effect of temperature management during cardiopulmonary bypass on neurologic and neuropsychologic outcomes in patients undergoing coronary revascularization. J Thorac. Cardiovasc. Surg., 1996, 112, 514-522.
154. McLean, R.F.; Wong, B.I.; Naylor, C.D.; Snow, W.G.; Harrington, E.M.; Gawel, M.; Fremes, S.E. Cardiopulmonary bypass, temperature, and central nervous system dysfunction. Circulation, 1994, 90, II250-255.
155. Martin, T.D.; Craver, J.M.; Gott, J.P.; Weintraub, W.S.; Ramsay, J.; Mora, C.T.; Guyton, R.A. Prospective, randomized trial of retrograde warm blood cardioplegia: myocardial benefit and neurologic threat. Ann. Thorac. Surg., 1994, 57, 298-302.
156. Nathan, H.J.; Wells, G.A.; Munson, J.L.; Wozny, D. Neuroprotective effect of mild hypothermia in patients undergoing coronary artery surgery with cardiopulmonary bypass: a randomized trial. Circulation, 2001, 104, I85-91.
157. Hammon, J.W.; Stump, D.A.; Butterworth, J.F.; Moody, D.M.; Rorie, K.; Deal, D.D.; Kincaid, E.H.; Oaks, T.E.; Kon, N.D. Single crossclamp improves 6-month cognitive outcome in high-risk coronary bypass patients: the effect of reduced aortic manipulation. J. Thorac. Cardiovasc. Surg., 2006, 131, 114-121.
158. Martens, S.; Dietrich, M.; Wals, S.; Steffen, S.; Wimmer-Greinecker, G.; Moritz, A. Conventional carbon dioxide application does not reduce cerebral or myocardial damage in open heart surgery. Ann. Thorac. Surg., 2001, 72, 1940-1944.
159. Payne, D.A.; Jones, C.I.; Hayes, P.D.; Thompson, M.M.; London, N.J.; Bell, P.R.; Goodall, A.H.; Naylor, A.R. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation, 2004, 109, 1476-1481.
160. van Mook, W.N.; Rennenberg, R.J.; Schurink, G.W.; van Oostenbrugge, R.J.; Mess, W.H.; Hofman, P.A.; de Leeuw, P.W. Cerebral hyperperfusion syndrome. Lancet Neurol., 2005, 4, 877-888.
161. Gold, J.; Charlson, M.; Williams-Russo, P.; Szatrowski, T.; Peterson, J.; Pirraglia, P.; Hartmann, G.; Yao, F.; Hollenberg, J.; Barbut, D.; Hayes, J.; Thomas, S.; Purcell, M.; Mattis, S.; Gorkin, L.; Post, M.; Krieger, K.; Isom, O. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean aterial pressure. J. Thorac. Cardiovasc. Surg., 1995, 110, 1302-1314.
162. Mathew, J.P.; Mackensen, G.B.; Phillips-Bute, B.; Stafford-Smith, M.; Podgoreanu, M.V.; Grocott, H.P.; Hill, S.E.; Smith, P.K.; Blumenthal, J.A.; Reves, J.G.; Newman, M.F. Effects of extreme hemodilution during cardiac surgery on cognitive function in the elderly. Anesthesiology, 2007, 107, 577-584.
163. Lautenschlager, N.T.; Cox, K.L.; Flicker, L.; Foster, J.K.; van Bockxmeer, F.M.; Xiao, J.; Greenop, K.R.; Almeida, O.P. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA, 2008, 300, 1027-1037.